● Recruiting

First in Human Pilot Study to Assess the Safety and Efficacy of Dendritic Cells Loaded With Frameshift Derived Neopeptides for the Prevention of Cancer in of Lynch Syndrome Carriers

Condition: Lynch Syndrome · Sponsor: Fundacion Clinic per a la Recerca Biomédica

PhasePhase 1

Planned participants20

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

Tha aim of this clinical trial is to evaluate safety and tolerability of autologous peripheral blood differentiated and matured adult dendritic cells. Immunogenicity of the prduct(DC-DELAY) will be evaluated also.

This description comes directly from the study's public registry record.

Talk to the study team

Laura Burunat, Graduate · 0034 932275400 · burunat@recerca.clinic.cat

Thomas Walle, Doctor of Medicine · 0034932275400 · WALLE@recerca.clinic.cat

Always discuss trial participation with your own doctor first.

Locations (1)

Laura Burunat

Barcelona, Barcelona, Spain

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07163403